Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Irwin N et al. – Glucose–dependent insulinotropic polypeptide (GIP or gastric inhibitory polypeptide) is a 42–amino–acid hormone, secreted from the enteroendocrine K cells, which has insulin–releasing and extrapancreatic glucoregulatory actions. Strong parallels exist with the beneficial metabolic effects of Roux–en–Y gastric bypass in obese, insulin–resistant humans that surgically ablates GIP–secreting K cells. The purpose of this article is to highlight the therapeutic potential of GIP–based therapeutics in the treatment of type 2 diabetes and obesity.

Today in Obesity...keeping you current

Muscular Strength Is Inversely Related to Prevalence and Incidence of Obesity in Adult Men
Obesity, 12/04/09

Forecasting the Effects of Obesity and Smoking on U.S. Life Expectancy
New England Journal of Medicine, 12/04/09

Getting heavier, younger: trajectories of obesity over the life course
International Journal of Obesity, 12/04/09

Today in Pharmacology/kinetics...keeping you current

The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case-control study
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/04/09

Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/04/09

Myxedema Coma Associated with Combination Aripiprazole and Sertraline Therapy
Annals of Pharmacotherapy, 12/03/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address